News | March 13, 2023
Zydus receives final approval from the USFDA for Olanzapine
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Digital success is contingent on the way a company organizes itself around technology
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Subscribe To Our Newsletter & Stay Updated
